Triamcinolone Acetonide Phosphoric Acid

Triamcinolone Acetonide Phosphoric Acid

SCHEMBL6544867

CC1(C)O[C@@H]2C[C@H]3[C@@H]4CCC5=CC(=O)C=C[C@]5(C)C4(F)[C@@H](O)C[C@]3(C)[C@]2(C(=O)COP(=O)([O-])[O-])O1.[Na+].[Na+]

nearest known ligand 0.78

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Triamcinolone Acetonide Phosphoric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR3C1 known ✓ P04150 5/20 0.78
▸ HIF1A Q16665 8/20 0.78
▸ LMNA P02545 5/20 0.78
▸ CYP3A4 P08684 5/20 0.78
▸ PGR P06401 4/20 0.78
▸ NR1I2 O75469 1/20 0.78
▸ MAPT P10636 3/20 0.70
▸ NPSR1 Q6W5P4 2/20 0.70
▸ CNR1 P21554 1/20 0.70
▸ KCNH2 Q12809 1/20 0.70
▸ USP2 O75604 1/20 0.70
▸ CHRM1 P11229 2/20 0.60
▸ CHRM4 P08173 1/20 0.60
▸ CHRM5 P08912 1/20 0.60
▸ CHRM3 P20309 1/20 0.60
▸ HRH1 P35367 1/20 0.60
▸ PIN1 Q13526 1/20 0.60
▸ CHRM2 P08172 1/20 0.60
▸ AR P10275 2/20 0.60
▸ ALDH1A1 P00352 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Triamcinolone Acetonide Phosphoric Acid SCHEMBL8856248 0.93 HIF1A (0.79) HIF1ALMNACYP3A4NR3C1PGR
Triamcinolone Acetonide SCHEMBL561411 0.91 HIF1A (0.91) HIF1ALMNACYP3A4NR3C1PGR
Triamcinolone Acetonide SCHEMBL1869303 0.90 HIF1A (0.89) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL13985471 0.90 LMNA (0.81) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL14114135 0.90 LMNA (0.83) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL13524485 0.90 LMNA (0.83) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL14884636 0.89 HIF1A (0.87) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL11422147 0.89 HIF1A (0.87) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL124165 0.89 HIF1A (0.87) HIF1ALMNACYP3A4NR3C1PGR
SCHEMBL15975096 0.89 HIF1A (0.87) HIF1ALMNACYP3A4NR3C1PGR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0954323-B1 PHARMACEUTICAL COMPOSITIONS COMPRISING A MIXTURE OF AUTOCROSS-LINKED HYALURONIC ACID AND NONAUTOCROSS-LINKED HYALURONIC ACID AND THEIR USE FOR THE TREATMENT OF ARTHROPATHIES FIDIA SPA (IT) 2004-01-07 — — EP disclosed
US-6251876-B1 PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ARTHROPATHIES COMPRISING AUTOCROSSLINKED HYALURONIC ACID, NONCROSSLINKED HYALURONIC ACID, PHARMACEUTICALLY ACCEPTABLE EXCIPIENT, DILUENT OR CARRIER FIDIA, S.P.A. (IT) 2001-06-26 — — US disclosed
EP-0954323-A1 AUTOCROSS-LINKED HYALURONIC ACID AND RELATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROPATHIES FIDIA S.p.A. (IT) 1999-11-10 — — EP disclosed
WO-1997049412-A1 AUTOCROSS-LINKED HYALURONIC ACID AND RELATED PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ARTHROPATHIES FIDIA S.P.A. (IT) 1997-12-31 — — WO disclosed
Send feedback